Skip to
  1. Homepage
  2. Research and trials
  3. Clinical trials
Search by disease/gene

Search by disease/gene

*
(*) mandatory field


 

Other search option(s)

64 matching term(s)

Caption : Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial

    • AUSTRIA
    • WIEN
    • WIEN
    • Recruiting trial
Ongoing trial
    • A randomized Phase 3, multicenter, Open-Label Study comparing TH-302 in Combination with Doxorubicin vs. Doxorubicin alone in subjects with locally advanced unresectable or metastatic soft tissue sarcoma - AT
    • Medizinische Universität Wien
    • Universitätsklinik für Innere Medizin I
    • More details
    • BELGIUM
    • ARRONDISSEMENT BRUSSELS-CAPITAL
    • NOT YET IDENTIFIED - BE
    • Recruiting trial
Ongoing trial
    • An Open-label, Multi-center, Randomized Study of the Safety and Effect on Event-free Survival of Bevacizumab in Combination With Standard Chemotherapy in Childhood and Adolescent Patients With Metastatic Rhabdomyosarcoma and Non-rhabdomyosarcoma Soft Tissue Sarcoma - BE
    • NOT YET IDENTIFIED - BE
    • More details
    • BELGIUM
    • ARRONDISSEMENT BRUSSELS-CAPITAL
    • NOT YET IDENTIFIED - BE
    • Ongoing trial
    • A randomized, open-label, multicenter, phase III study to compare the efficacy and safety of Eribulin with Dacarbazine in subjects with Soft tissue sarcoma - BE
    • NOT YET IDENTIFIED - BE
    • More details
    • BELGIUM
    • ARRONDISSEMENT BRUSSELS-CAPITAL
    • NOT YET IDENTIFIED - BE
    • Ongoing trial
    • A randomized Phase 3, multicenter, Open-Label Study comparing TH-302 in Combination with Doxorubicin vs. Doxorubicin alone in subjects with locally advanced unresectable or metastatic soft tissue sarcoma - BE
    • NOT YET IDENTIFIED - BE
    • More details
    • DENMARK
    • Jylland
    • NOT YET IDENTIFIED - DK
    • Recruiting trial
Ongoing trial
    • Phase 1/2 Efficacy, Safety of Plerixafor in Addition to Standard Regimens for Mobilisation of Haematopoietic Stem Cells into Peripheral Blood, and Subsequent Collection by Apheresis, Versus Standard Mobilisation Regimens Alone in Paediatric Patients, with Solid Tumours Eligible for Autologous Transplants - DK
    • NOT YET IDENTIFIED - DK
    • More details
    • FRANCE
    • ILE-DE-FRANCE
    • VILLEJUIF
    • Recruiting trial
Ongoing trial
    • LMS02 : Phase II, multicentric trial evaluating the efficacity of doxorubicin in combination with trabectedin (Yondelis) in first line treatment of patients with metastatic leiomyosarcoma (uterine or soft tissue) and/or recurrent inoperable.
    • CLCC Institut de cancérologie Gustave Roussy
    • Service Gynécologie
    • More details
    • FRANCE
    • PROVENCE-ALPES-COTE D'AZUR
    • MARSEILLE
    • Randomised trial of single agent doxorubicin versus doxorubicin plus ifosfamide in the first treatment of advanced or metastatic soft tissue sarcoma (Phase III) -Terminated -
    • CHU de Marseille - Hôpital de la Timone
    • Service d'oncologie médicale
    • More details
    • FRANCE
    • PROVENCE-ALPES-COTE D'AZUR
    • MARSEILLE
    • Ongoing trial
    • Phase II pharmacokinetic study to assess doxorubicin clearance age-dependency in pediatric patients with solid tumours and leukemia - FR
    • CHU de Marseille - Hôpital de la Timone
    • Service d'oncologie pédiatrique
    • More details
    • FRANCE
    • RHONE-ALPES
    • LYON
    • Recruiting trial
Ongoing trial
    • Multicenter, prospective, open-label, uncontrolled study in patients aged 45 years or older to evaluate the efficacy and safety of Liposomal Doxorubicin (Doxorubicin GP-Pharm) in first-line treatment in soft-tissue sarcomas (Phase I-II) - FR
    • CLCC Léon Bérard
    • Centre Léon Bérard
    • More details
    • FRANCE
    • RHONE-ALPES
    • LYON
    • Recruiting trial
Ongoing trial
    • ESTIM : Efficacy and safety assessment of oral LBH589 in adult patients with advanced soft tissue sarcoma after doxorubicin failure : an open-label, multi-centric phase II study
    • CLCC Léon Bérard
    • Centre Léon Bérard
    • More details
    • FRANCE
    • RHONE-ALPES
    • LYON
    • Recruiting trial
Ongoing trial
    • Etude de phase I, escalade de doses évaluant le sunitinib en administration continue associé ŕ une radiothérapie concomitante dans les sarcomes non-GIST inopérables - FR
    • CLCC Léon Bérard
    • Centre Léon Bérard
    • More details
    • FRANCE
    • RHONE-ALPES
    • LYON
    • Recruiting trial
Ongoing trial
    • Multicenter phase I/II study of continuous dosing of Sunitinib in non-GIST sarcomas with concomitant radiation therapy.
    • CLCC Léon Bérard
    • Département de radiothérapie
    • More details
    • FRANCE
    • RHONE-ALPES
    • NOT YET IDENTIFIED - FR
    • Multicenter, prospective, open-label, uncontrolled study in patients aged 45 years or older to evaluate the efficacy and safety of Liposomal Doxorubicin (Doxorubicin GP-Pharm) in first-line treatment in soft-tissue sarcomas - FR
    • NOT YET IDENTIFIED - FR
    • More details
    • FRANCE
    • RHONE-ALPES
    • NOT YET IDENTIFIED - FR
    • Recruiting trial
Ongoing trial
    • Phase 1/2 Efficacy, Safety of Plerixafor in Addition to Standard Regimens for Mobilisation of Haematopoietic Stem Cells into Peripheral Blood, and Subsequent Collection by Apheresis, Versus Standard Mobilisation Regimens Alone in Paediatric Patients, with Solid Tumours Eligible for Autologous Transplants - FR
    • NOT YET IDENTIFIED - FR
    • More details
    • FRANCE
    • RHONE-ALPES
    • NOT YET IDENTIFIED - FR
    • Recruiting trial
Ongoing trial
    • An Open-label, Multi-center, Randomized Study of the Safety and Effect on Event-free Survival of Bevacizumab in Combination With Standard Chemotherapy in Childhood and Adolescent Patients With Metastatic Rhabdomyosarcoma and Non-rhabdomyosarcoma Soft Tissue Sarcoma - FR
    • NOT YET IDENTIFIED - FR
    • More details
    • FRANCE
    • RHONE-ALPES
    • NOT YET IDENTIFIED - FR
    • Ongoing trial
    • Phase II Study of GW786034 in Patients With Relapsed or Refractory Soft Tissue Sarcoma - FR
    • NOT YET IDENTIFIED - FR
    • More details
    • FRANCE
    • RHONE-ALPES
    • NOT YET IDENTIFIED - FR
    • A Randomized Double Blind Phase III Trial of Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy - FR
    • NOT YET IDENTIFIED - FR
    • More details
    • FRANCE
    • RHONE-ALPES
    • NOT YET IDENTIFIED - FR
    • Recruiting trial
Ongoing trial
    • A randomized Phase 3, multicenter, Open-Label Study comparing TH-302 in Combination with Doxorubicin vs. Doxorubicin alone in subjects with locally advanced unresectable or metastatic soft tissue sarcoma - FR
    • NOT YET IDENTIFIED - FR
    • More details
    • GERMANY
    • Baden-Württemberg
    • HEIDELBERG
    • Recruiting trial
Ongoing trial
    • SAHA-I: A Phase II Study to investigate the efficacy and tolerability of Vorinostat in patients suffering from advanced, metastatic Soft Tissue Sarcoma
    • Universitätsklinikum Heidelberg
    • Abteilung Innere Medizin V - Hämatologie, Onkologie und Rheumatologie
    • More details
    • GERMANY
    • Baden-Württemberg
    • MANNHEIM
    • Recruiting trial
Ongoing trial
    • A Randomized phase 3, multicenter, open-label study comparing TH-302 in combination with Doxorubicin vs. Doxorubicin alone in subjects with locally advanced unresectable or metastatic Soft Tissue Sarcoma (TH-CR-406/SARC021) - DE
    • Universitätsklinikum Mannheim
    • Sarkom-Zentrum
    • More details
    • GERMANY
    • Baden-Württemberg
    • STUTTGART
    • Ongoing trial
    • EURO-B.O.S.S.: A European treatment protocol for bone sarcoma in patients older than 40 years - DE
    • Klinikum Stuttgart - Standort Olgahospital
    • COSS (Cooperative OsteoSarkom Studiengruppe) Studienzentrale
    • More details
    • GERMANY
    • Bayern
    • MÜNCHEN
    • EORTC 62961: Phase III randomized study of neoadjuvant Etoposide, Ifosfamide, and Doxorubicin with or without regional hyperthermia in patients with high-risk soft tissue sarcoma - Terminated
    • LMU Klinikum der Universität München - Campus Großhadern
    • Medizinische Klinik und Poliklinik III
    • More details
    • GERMANY
    • Berlin
    • NOT YET IDENTIFIED - DE
    • Ongoing trial
    • A Phase 1/2 comparative study of the efficacy and safety of Plerixafor in addition to standard regimens for mobilization of haematopoietic stem cells into peripheral blood, and subsequent collection by apheresis, versus standard mobilization regimens alone in pediatric patients with Solid Tumours eligible for autologous transplants - DE
    • Not yet identified - DE
    • More details
    • GERMANY
    • Niedersachsen
    • HANNOVER
    • Recruiting trial
Ongoing trial
    • EPAZ (GISG-05): A randomized phase II trial comparing Pazopanib with Doxorubicin as first line treatment in elderly patients with metastatic or advanced Soft Tissue Sarcoma - DE
    • Medizinische Hochschule Hannover
    • Klinik für Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation
    • More details
    • GERMANY
    • Nordrhein-Westfalen
    • KÖLN
    • Ongoing trial
    • EORTC 62072 (PALETTE) - A randomized, double blind phase III trial of Pazopanib versus Placebo in patients with Soft Tissue Sarcoma whose disease has progressed during or following prior therapy - DE
    • Universitätsklinikum Köln
    • Klinik I für Innere Medizin - AG Prof. Wendtner
    • More details
    • GERMANY
    • Nordrhein-Westfalen
    • KÖLN
    • Recruiting trial
Ongoing trial
    • PICASSO III: A Phase III multicenter, international, randomized, double-blind, placebo-controlled study of Doxorubicin plus Palifosfamide-tris versus Doxorubicin plus Placebo in patients with front-line metastatic Soft Tissue Sarcoma - DE
    • Universitätsklinikum Köln
    • Klinik I für Innere Medizin - AG Prof. Wendtner
    • More details
    • GERMANY
    • Sachsen
    • DRESDEN
    • Recruiting trial
Ongoing trial
    • A randomized, open-label, multicenter, phase III study to compare the efficacy and safety of Eribulin with Dacarbazine in subjects with Soft tissue sarcoma - DE
    • Universitätsklinikum Carl Gustav Carus an der TU Dresden
    • Medizinische Klinik und Poliklinik I
    • More details
    • GERMANY
    • Schleswig-Holstein
    • KIEL
    • Recruiting trial
Ongoing trial
    • A Phase II Trial of R1507, a recombinant human monoclonal antibody to the insulin-like growth factor-1 receptor for the treatment of patients with recurrent or refractory Ewing's Sarcoma, recurrent or refractory Osteosarcoma, Synovial Sarcoma, Rhabdomyosarcoma and other Sarcomas
    • Universitätsklinikum Schleswig-Holstein - Campus Kiel
    • Krebszentrum Nord
    • More details
    • GERMANY
    • Schleswig-Holstein
    • KIEL
    • Recruiting trial
Ongoing trial
    • Randomized Phase II Trial of Trofosfamide vs. Adriamycin in elderly patients with previously untreated metastatic Soft Tissue Sarcoma
    • Universitätsklinikum Schleswig-Holstein - Campus Kiel
    • Krebszentrum Nord
    • More details
    • IRELAND
    • County Dublin
    • NOT YET IDENTIFIED - IE
    • Recruiting trial
Ongoing trial
    • European Paediatric Soft Tissue Sarcoma Study Group protocol for Localized Non-Rhabdomyosarcoma Soft Tissue Sarcomas 2005 (phase III) - IE
    • NOT YET IDENTIFIED - IE
    • More details
    • NETHERLANDS
    • Utrecht
    • NOT YET IDENTIFIED - NL
    • Ongoing trial
    • Phase 1/2 Efficacy, Safety of Plerixafor in Addition to Standard Regimens for Mobilisation of Haematopoietic Stem Cells into Peripheral Blood, and Subsequent Collection by Apheresis, Versus Standard Mobilisation Regimens Alone in Paediatric Patients, with Solid Tumours Eligible for Autologous Transplants
    • NOT YET IDENTIFIED - NL
    • More details
    • SPAIN
    • Baleares
    • PALMA DE MALLORCA
    • Ongoing trial
    • Randomized, open, multicenter, prospective, Phase II clinical trial of Doxorubicin vs. Trabectedin plus Doxorubicin in the first line treatment of patients with advanced non operable and/or metastatic soft tissue sarcomas
    • Hospital Universitario Son Espases
    • Telecomité de Tumores Musculoesqueléticos (COTMES)
    • More details
    • SPAIN
    • Cataluńa
    • BARCELONA
    • Ongoing trial
    • Localized Non-Rhabdomyosarcoma Soft Tissue Sarcomas (Phase III)
    • Hospital Universitari Vall d'Hebron - Area Materno Infantil
    • Servicio de Oncología y Hematología Pediátricas
    • More details
    • SPAIN
    • Cataluńa
    • BARCELONA
    • Recruiting trial
Ongoing trial
    • A Phase 1/2 Combined Dose Ranging and Randomized, Open-label, Comparative Study of the Efficacy and Safety of Plerixafor in Addition to Standard Regimens for Mobilization of Haematopoietic Stem Cells Into Peripheral Blood, and Subsequent Collection by Apheresis, Versus Standard Mobilization Regimens Alone in Pediatric Patients, Aged 2 to <18 Years [...] - ES
    • Hospital Universitari Vall d'Hebron - Area Materno Infantil
    • Servicio de Oncología y Hematología Pediátricas
    • More details
    • SPAIN
    • Cataluńa
    • BARCELONA
    • A Five-Tier, Phase 2 Open-Label Study of IMC-A12 Administered as a Single Agent Every 2 Weeks in Patients With Previously- Treated, Advanced or Metastatic Soft Tissue and Ewing's Sarcoma/PNET (Peripheral Neuroectodermal Tumor) - ES (completed)
    • Hospital de la Santa Creu i Sant Pau
    • Servicio de Oncología Médica (H. de la Santa Creu i Sant Pau)
    • More details
    • SPAIN
    • Cataluńa
    • L'HOSPITALET DE LLOBREGAT
    • A Five-Tier, Phase 2 Open-Label Study of IMC-A12 Administered as a Single Agent Every 2 Weeks in Patients With Previously- Treated, Advanced or Metastatic Soft Tissue and Ewing's Sarcoma/PNET (Peripheral Neuroectodermal Tumor) - ES (completed)
    • ICO L'Hospitalet
    • Servicio de Oncología Médica (ICO L'Hospitalet)
    • More details
    • SPAIN
    • Cataluńa
    • L'HOSPITALET DE LLOBREGAT
    • Ongoing trial
    • Phase I-II, Not-Randomized, Multicenter Clinical Trial to Evaluate Safety and Efficacy of Sorafenib (BAY-43-9006) in Combination With Ifosfamide in Soft Tissue Sarcoma
    • ICO L'Hospitalet
    • Servicio de Oncología Médica (ICO L'Hospitalet)
    • More details
    • SPAIN
    • Cataluńa
    • L'HOSPITALET DE LLOBREGAT
    • Phase II Study of Neoadyuvant High-dose Ifosfamide and Concurrent Radiotherapy in Soft Tissue Sarcoma and Identification of Response Predictors (completed)
    • ICO L'Hospitalet
    • Servicio de Oncología Médica (ICO L'Hospitalet)
    • More details
    • SPAIN
    • Cataluńa
    • L'HOSPITALET DE LLOBREGAT
    • Ongoing trial
    • A Randomized Phase 3, Multicenter, Open-Label Study Comparing TH-302 in Combination With Doxorubicin vs. Doxorubicin Alone in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma - ES
    • ICO L'Hospitalet
    • Servicio de Oncología Médica (ICO L'Hospitalet)
    • More details
    • SPAIN
    • Comunidad Valenciana
    • VALENCIA
    • Ongoing trial
    • Randomized, open, multicenter, prospective, Phase II clinical trial of Doxorubicin vs. Trabectedin plus Doxorubicin in the first line treatment of patients with advanced non operable and/or metastatic soft tissue sarcomas
    • Fundación Instituto Valenciano de Oncología
    • Servicio de Oncología Médica (IVO)
    • More details
    • SPAIN
    • Madrid
    • MADRID
    • TRUSTS: A Phase IIB/III Multicenter Study Comparing the Efficacy of TRabectedin Administered as a 3-Hour or 24-Hour Infusion to Doxorubicin in Patients With Advanced or Metastatic Untreated Soft Tissue Sarcoma - ES (terminated)
    • Hospital Clínico San Carlos
    • Servicio de Oncología Médica (H.C. San Carlos)
    • More details
    • SPAIN
    • Madrid
    • MAJADAHONDA
    • PICASSO III: A Phase III Multicenter, International, Randomized, Double-blind, Placebo-controlled Study of Doxorubicin Plus Palifosfamide-tris vs. Doxorubicin Plus Placebo in Patients With Front-line Metastatic Soft Tissue Sarcoma (completed)
    • Hospital Universitario Puerta de Hierro
    • Servicio de Oncología Médica (H. Puerta de Hierro)
    • More details
    • SPAIN
    • Madrid
    • NOT YET IDENTIFIED - ES
    • Ongoing trial
    • A Multinational, Randomized, Double-Blind Placebo Controlled Study of AVE8062 (25 mg/m2) Administered Every 3 Weeks in Patients With Advanced-Stage Soft Tissue Sarcoma, Treated With Cisplatin (75 mg) After Failure of Anthracycline and Ifosfamide Chemotherapies (Phase II-III) (completed)
    • NOT YET IDENTIFIED - ES
    • More details
    • SPAIN
    • Madrid
    • NOT YET IDENTIFIED - ES
    • PALETTE: A Randomized Double Blind Phase III Trial of Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy (completed)
    • NOT YET IDENTIFIED - ES
    • More details
    • SPAIN
    • Madrid
    • NOT YET IDENTIFIED - ES
    • Multicenter, prospective, open-label, uncontrolled study in patients aged 45 years or older to evaluate the efficacy and safety of Liposomal Doxorubicin (Doxorubicin GP-Pharm) in first-line treatment in soft-tissue sarcomas (Phase I-II) - ES (Completed)
    • NOT YET IDENTIFIED - ES
    • More details
    • SPAIN
    • Madrid
    • NOT YET IDENTIFIED - ES
    • Ongoing trial
    • A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue Sarcoma - ES
    • NOT YET IDENTIFIED - ES
    • More details
    • SPAIN
    • Madrid
    • NOT YET IDENTIFIED - ES
    • Ongoing trial
    • Localized high-risk soft tissue sarcomas of the extremities and trunk wall in adults: an integrating approach comprising standard vs histotype-tailored neoadjuvant chemotherapy (Phase III)
    • NOT YET IDENTIFIED - ES
    • More details
    • SPAIN
    • Madrid
    • NOT YET IDENTIFIED - ES
    • Recruiting trial
Ongoing trial
    • Open-label, multi-center, randomized, phase II study evaluating the addition of bevacizumab to chemotherapy in childhood and adolescent patients presenting with metastatic rhabdomyosarcoma and non-rhabdomyosarcoma soft tissue sarcoma - ES
    • NOT YET IDENTIFIED - ES
    • More details
    • UNITED KINGDOM
    • Cambridgeshire
    • CAMBRIDGE
    • Recruiting trial
Ongoing trial
    • Uterine LMS study: A Phase III Randomised Trial of Gemcitabine plus Docetaxel followed by Doxorubicin versus observation for uterus-limited, high grade uterine leiomyosarcoma - UK
    • Addenbrooke's Hospital
    • Department of Oncology
    • More details
    • UNITED KINGDOM
    • Greater London
    • LONDON
    • Recruiting trial
Ongoing trial
    • A Phase 1/2, First in Human, Single-arm, Open-label Study of Once a Day, Orally Administered BMN 673 in Patients with Advanced or Recurrent Solid Tumors - UK
    • Royal Marsden Hospital
    • Drug Development Unit
    • More details
    • UNITED KINGDOM
    • Greater London
    • SURREY
    • Recruiting trial
Ongoing trial
    • FGFR Study: Proof-of-concept study of AZD 4547 in patients with FGFR1 or FGFR2 amplified tumours - UK
    • The Royal Marsdon
    • Department of Medicine
    • More details
    • UNITED KINGDOM
    • Greater Manchester
    • MANCHESTER
    • Ongoing trial
    • TRUSTS: A Phase IIb/III Multicenter Study Comparing the Efficacy of TRabectedin Administered as a 3-Hour or 24-Hour Infusion to Doxorubicin in Patients With Advanced or Metastatic Untreated Soft Tissue Sarcoma - UK
    • Central Manchester University Hospitals - Manchester Royal Infirmary
    • Department of Orthopaedic Surgery
    • More details
    • UNITED KINGDOM
    • Greater Manchester
    • MANCHESTER
    • Recruiting trial
Ongoing trial
    • European Paediatric Soft Tissue Sarcoma Study Group protocol for Localized Non-Rhabdomyosarcoma Soft Tissue Sarcomas 2005 (phase III) - UK
    • Royal Manchester Children's Hospital
    • Department of Oncology
    • More details
    • UNITED KINGDOM
    • Greater Manchester
    • MANCHESTER
    • Ongoing trial
    • A Randomised, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin with Dacarbazine in Subjects with Soft Tissue Sarcoma - UK
    • The Christie NHS Foundation Trust, Cancer Information Centre
    • The Christie Clinic
    • More details
    • UNITED KINGDOM
    • Greater Manchester
    • NOT YET IDENTIFIED - UK
    • Ongoing trial
    • Phase 1/2 Efficacy, Safety of Plerixafor in Addition to Standard Regimens for Mobilisation of Haematopoietic Stem Cells into Peripheral Blood, and Subsequent Collection by Apheresis, Versus Standard Mobilisation Regimens Alone in Paediatric Patients, with Solid Tumours Eligible for Autologous Transplants - UK
    • NOT YET IDENTIFIED - UK
    • More details
    • UNITED KINGDOM
    • Greater Manchester
    • NOT YET IDENTIFIED - UK
    • Recruiting trial
Ongoing trial
    • Open-label, multi-center, randomized, phase II study evaluating the addition of bevacizumab to chemotherapy in childhood and adolescent patients presenting with metastatic rhabdomyosarcoma and non-rhabdomyosarcoma soft tissue sarcoma - UK
    • NOT YET IDENTIFIED - UK
    • More details
    • UNITED KINGDOM
    • Greater Manchester
    • NOT YET IDENTIFIED - UK
    • Recruiting trial
Ongoing trial
    • An Open-Label Phase I/IIa Study of Intravenous BAL101553 in Adult Patients with Advanced Solid Tumors
    • NOT YET IDENTIFIED - UK
    • More details
    • UNITED KINGDOM
    • Greater Manchester
    • NOT YET IDENTIFIED - UK
    • Ongoing trial
    • NGR016: Randomized phase II study evaluating two doses of NGR-hTNF administered either as single agent or in combination with doxorubicin in patients with advanced soft-tissue sarcoma (STS) - UK
    • NOT YET IDENTIFIED - UK
    • More details
    • UNITED KINGDOM
    • Greater Manchester
    • NOT YET IDENTIFIED - UK
    • Ongoing trial
    • A Randomized, Multicenter, Phase III Trial of Trabectedin (Yondelis®) versus Doxorubicin-based Chemotherapy as First-Line Therapy in Patients with Translocation-Related Sarcomas (TRS) - UK
    • NOT YET IDENTIFIED - UK
    • More details
    • UNITED KINGDOM
    • Greater Manchester
    • NOT YET IDENTIFIED - UK
    • Ongoing trial
    • PICASSO III: A Phase III multicenter, international, randomized, double-blind, placebo-controlled study of doxorubicin plus palifosfamide-tris vs. doxorubicin plus placebo in patients with front-line metastatic soft tissue sarcoma - UK
    • NOT YET IDENTIFIED - UK
    • More details
    • UNITED KINGDOM
    • Greater Manchester
    • NOT YET IDENTIFIED - UK
    • Ongoing trial
    • PALETTE: A Randomized Double Blind Phase III Trial of Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy - UK
    • NOT YET IDENTIFIED - UK
    • More details
    • UNITED KINGDOM
    • South Yorkshire
    • SHEFFIELD
    • Recruiting trial
Ongoing trial
    • Axi-STS: A clinicopathological phase II study of axitinib in patients with advanced angiosarcoma and other soft tissue sarcomas
    • Weston Park Hospital
    • Cancer Clinical Trials Centre
    • More details
    • UNITED KINGDOM
    • South Yorkshire
    • SHEFFIELD
    • EORTC 62931: Randomized phase III trial of adjuvant chemotherapy with high-dose doxorubicin, ifosfamide and lenograstim in high grade soft tissue sarcoma - UK (Completed)
    • Weston Park Hospital
    • Cancer Clinical Trials Centre
    • More details
    • UNITED KINGDOM
    • Tyne & Wear
    • NEWCASTLE UPON TYNE
    • Ongoing trial
    • EPOC-MS-001 - Phase II pharmacokinetic study to assess the age-dependency in the clearance of Doxorubicin in paediatric patients with Solid Tumours and Leukaemia - UK
    • Northern Institute for Cancer Research, Medical School, Newcastle University
    • Northern Institute for Cancer Research
    • More details